China National Medicines Corp Equity 2024

Equity Details

Analyzing China National Medicines Corp's Equity

China National Medicines Corp's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding China National Medicines Corp's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating China National Medicines Corp's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

China National Medicines Corp's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in China National Medicines Corp’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about China National Medicines Corp Stock

What is the equity of China National Medicines Corp this year?

China National Medicines Corp has equity of 15.78 B CNY this year.

What was the equity of China National Medicines Corp compared to the previous year?

The equity of China National Medicines Corp has increased/decreased by 10.98% increased compared to the previous year.

What impact does a high equity have on investors of China National Medicines Corp?

A high equity is advantageous for investors of China National Medicines Corp as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of China National Medicines Corp?

A low equity can be a risk for investors of China National Medicines Corp, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of China National Medicines Corp affect the company?

An increase in equity of China National Medicines Corp can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of China National Medicines Corp affect the company?

A reduction in equity of China National Medicines Corp can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of China National Medicines Corp?

Some factors that can affect the equity of China National Medicines Corp include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of China National Medicines Corp so important for investors?

The equity of China National Medicines Corp is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can China National Medicines Corp take to change the equity?

To change equity, China National Medicines Corp can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does China National Medicines Corp pay?

Over the past 12 months, China National Medicines Corp paid a dividend of 0.78 CNY . This corresponds to a dividend yield of about 2.5 %. For the coming 12 months, China National Medicines Corp is expected to pay a dividend of 0.86 CNY.

What is the dividend yield of China National Medicines Corp?

The current dividend yield of China National Medicines Corp is 2.5 %.

When does China National Medicines Corp pay dividends?

China National Medicines Corp pays a quarterly dividend. This is distributed in the months of July, July, July, July.

How secure is the dividend of China National Medicines Corp?

China National Medicines Corp paid dividends every year for the past 23 years.

What is the dividend of China National Medicines Corp?

For the upcoming 12 months, dividends amounting to 0.86 CNY are expected. This corresponds to a dividend yield of 2.75 %.

In which sector is China National Medicines Corp located?

China National Medicines Corp is assigned to the 'Health' sector.

Wann musste ich die Aktien von China National Medicines Corp kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of China National Medicines Corp from 6/9/2023 amounting to 0.782 CNY, you needed to have the stock in your portfolio before the ex-date on 6/9/2023.

When did China National Medicines Corp pay the last dividend?

The last dividend was paid out on 6/9/2023.

What was the dividend of China National Medicines Corp in the year 2023?

In the year 2023, China National Medicines Corp distributed 0.7 CNY as dividends.

In which currency does China National Medicines Corp pay out the dividend?

The dividends of China National Medicines Corp are distributed in CNY.